Review



lepr  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems lepr
    Lepr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 70 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lepr/product/R&D Systems
    Average 95 stars, based on 70 article reviews
    lepr - by Bioz Stars, 2026-05
    95/100 stars

    Images



    Similar Products

    lep  (Bioss)
    94
    Bioss lep
    Molecular docking models of Astragaloside IV (AS-IV) binding to the core targets. Representative binding poses of AS-IV (shown in stick representation) within the predicted binding pockets of the key target proteins. The calculated binding free energy (kcal/mol) for each complex is indicated. (A) Il22ra2 (−10.2 kcal/mol), (B) Ptgs2 (−9.5 kcal/mol), (C) Wnt1 (−9.3 kcal/mol), <t>(D)</t> <t>Igfbp2</t> (−8.4 kcal/mol), (E) GZMB (−8.2 kcal/mol), (F) <t>Lep</t> (−7.8 kcal/mol), (G) Gfap (−7.8 kcal/mol), (H) Wnt10a (−7.7 kcal/mol). These results demonstrate stable binding interactions between the therapeutic compound AS-IV and all eight core targets identified from the PPI network and WGCNA, with Il22ra2 and Ptgs2 showing the strongest binding affinity.
    Lep, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lep/product/Bioss
    Average 94 stars, based on 1 article reviews
    lep - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    95
    R&D Systems lepr
    Molecular docking models of Astragaloside IV (AS-IV) binding to the core targets. Representative binding poses of AS-IV (shown in stick representation) within the predicted binding pockets of the key target proteins. The calculated binding free energy (kcal/mol) for each complex is indicated. (A) Il22ra2 (−10.2 kcal/mol), (B) Ptgs2 (−9.5 kcal/mol), (C) Wnt1 (−9.3 kcal/mol), <t>(D)</t> <t>Igfbp2</t> (−8.4 kcal/mol), (E) GZMB (−8.2 kcal/mol), (F) <t>Lep</t> (−7.8 kcal/mol), (G) Gfap (−7.8 kcal/mol), (H) Wnt10a (−7.7 kcal/mol). These results demonstrate stable binding interactions between the therapeutic compound AS-IV and all eight core targets identified from the PPI network and WGCNA, with Il22ra2 and Ptgs2 showing the strongest binding affinity.
    Lepr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lepr/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    lepr - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    93
    R&D Systems murine lepr
    Molecular docking models of Astragaloside IV (AS-IV) binding to the core targets. Representative binding poses of AS-IV (shown in stick representation) within the predicted binding pockets of the key target proteins. The calculated binding free energy (kcal/mol) for each complex is indicated. (A) Il22ra2 (−10.2 kcal/mol), (B) Ptgs2 (−9.5 kcal/mol), (C) Wnt1 (−9.3 kcal/mol), <t>(D)</t> <t>Igfbp2</t> (−8.4 kcal/mol), (E) GZMB (−8.2 kcal/mol), (F) <t>Lep</t> (−7.8 kcal/mol), (G) Gfap (−7.8 kcal/mol), (H) Wnt10a (−7.7 kcal/mol). These results demonstrate stable binding interactions between the therapeutic compound AS-IV and all eight core targets identified from the PPI network and WGCNA, with Il22ra2 and Ptgs2 showing the strongest binding affinity.
    Murine Lepr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine lepr/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    murine lepr - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    R&D Systems immunofluorescence
    Molecular docking models of Astragaloside IV (AS-IV) binding to the core targets. Representative binding poses of AS-IV (shown in stick representation) within the predicted binding pockets of the key target proteins. The calculated binding free energy (kcal/mol) for each complex is indicated. (A) Il22ra2 (−10.2 kcal/mol), (B) Ptgs2 (−9.5 kcal/mol), (C) Wnt1 (−9.3 kcal/mol), <t>(D)</t> <t>Igfbp2</t> (−8.4 kcal/mol), (E) GZMB (−8.2 kcal/mol), (F) <t>Lep</t> (−7.8 kcal/mol), (G) Gfap (−7.8 kcal/mol), (H) Wnt10a (−7.7 kcal/mol). These results demonstrate stable binding interactions between the therapeutic compound AS-IV and all eight core targets identified from the PPI network and WGCNA, with Il22ra2 and Ptgs2 showing the strongest binding affinity.
    Immunofluorescence, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immunofluorescence/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    immunofluorescence - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    R&D Systems human lepr
    Molecular docking models of Astragaloside IV (AS-IV) binding to the core targets. Representative binding poses of AS-IV (shown in stick representation) within the predicted binding pockets of the key target proteins. The calculated binding free energy (kcal/mol) for each complex is indicated. (A) Il22ra2 (−10.2 kcal/mol), (B) Ptgs2 (−9.5 kcal/mol), (C) Wnt1 (−9.3 kcal/mol), <t>(D)</t> <t>Igfbp2</t> (−8.4 kcal/mol), (E) GZMB (−8.2 kcal/mol), (F) <t>Lep</t> (−7.8 kcal/mol), (G) Gfap (−7.8 kcal/mol), (H) Wnt10a (−7.7 kcal/mol). These results demonstrate stable binding interactions between the therapeutic compound AS-IV and all eight core targets identified from the PPI network and WGCNA, with Il22ra2 and Ptgs2 showing the strongest binding affinity.
    Human Lepr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human lepr/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    human lepr - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    R&D Systems goat anti lepr polyclonal antibody
    Molecular docking models of Astragaloside IV (AS-IV) binding to the core targets. Representative binding poses of AS-IV (shown in stick representation) within the predicted binding pockets of the key target proteins. The calculated binding free energy (kcal/mol) for each complex is indicated. (A) Il22ra2 (−10.2 kcal/mol), (B) Ptgs2 (−9.5 kcal/mol), (C) Wnt1 (−9.3 kcal/mol), <t>(D)</t> <t>Igfbp2</t> (−8.4 kcal/mol), (E) GZMB (−8.2 kcal/mol), (F) <t>Lep</t> (−7.8 kcal/mol), (G) Gfap (−7.8 kcal/mol), (H) Wnt10a (−7.7 kcal/mol). These results demonstrate stable binding interactions between the therapeutic compound AS-IV and all eight core targets identified from the PPI network and WGCNA, with Il22ra2 and Ptgs2 showing the strongest binding affinity.
    Goat Anti Lepr Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti lepr polyclonal antibody/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    goat anti lepr polyclonal antibody - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    95
    R&D Systems mouse leptin receptor lepr biotinylated antibody
    Effect of implanted fillers on the recruitment of PSCs and ingrowth of blood vessels following implantation in the periosteum of rat skull for a duration of 1 month. Scale bars, 100 μm. A Representative immunostainings of <t>LepR+</t> PSCs, Emcn+ vessels, and OPN+ mature osteoblast in HA and PCL fillers. B , C Quantification of the relative Emcn+ vessel area in implants ( B ) and peri-implants ( C ). D Quantification of the relative LepR+ area in implants. Data are means ± SD. * P < 0.05, and *** P < 0.005 (unpaired two-tailed Student’s t test)
    Mouse Leptin Receptor Lepr Biotinylated Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse leptin receptor lepr biotinylated antibody/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    mouse leptin receptor lepr biotinylated antibody - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    93
    Proteintech scd1
    Effect of implanted fillers on the recruitment of PSCs and ingrowth of blood vessels following implantation in the periosteum of rat skull for a duration of 1 month. Scale bars, 100 μm. A Representative immunostainings of <t>LepR+</t> PSCs, Emcn+ vessels, and OPN+ mature osteoblast in HA and PCL fillers. B , C Quantification of the relative Emcn+ vessel area in implants ( B ) and peri-implants ( C ). D Quantification of the relative LepR+ area in implants. Data are means ± SD. * P < 0.05, and *** P < 0.005 (unpaired two-tailed Student’s t test)
    Scd1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/scd1/product/Proteintech
    Average 93 stars, based on 1 article reviews
    scd1 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Proteintech lep
    Effect of implanted fillers on the recruitment of PSCs and ingrowth of blood vessels following implantation in the periosteum of rat skull for a duration of 1 month. Scale bars, 100 μm. A Representative immunostainings of <t>LepR+</t> PSCs, Emcn+ vessels, and OPN+ mature osteoblast in HA and PCL fillers. B , C Quantification of the relative Emcn+ vessel area in implants ( B ) and peri-implants ( C ). D Quantification of the relative LepR+ area in implants. Data are means ± SD. * P < 0.05, and *** P < 0.005 (unpaired two-tailed Student’s t test)
    Lep, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lep/product/Proteintech
    Average 93 stars, based on 1 article reviews
    lep - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    Image Search Results


    Molecular docking models of Astragaloside IV (AS-IV) binding to the core targets. Representative binding poses of AS-IV (shown in stick representation) within the predicted binding pockets of the key target proteins. The calculated binding free energy (kcal/mol) for each complex is indicated. (A) Il22ra2 (−10.2 kcal/mol), (B) Ptgs2 (−9.5 kcal/mol), (C) Wnt1 (−9.3 kcal/mol), (D) Igfbp2 (−8.4 kcal/mol), (E) GZMB (−8.2 kcal/mol), (F) Lep (−7.8 kcal/mol), (G) Gfap (−7.8 kcal/mol), (H) Wnt10a (−7.7 kcal/mol). These results demonstrate stable binding interactions between the therapeutic compound AS-IV and all eight core targets identified from the PPI network and WGCNA, with Il22ra2 and Ptgs2 showing the strongest binding affinity.

    Journal: Frontiers in Nutrition

    Article Title: Astragaloside IV modulates oxidative stress and osteoimmune–Wnt signaling in ovariectomized rats: an integrated study of RNA sequencing, molecular docking, and experimental validation

    doi: 10.3389/fnut.2026.1785452

    Figure Lengend Snippet: Molecular docking models of Astragaloside IV (AS-IV) binding to the core targets. Representative binding poses of AS-IV (shown in stick representation) within the predicted binding pockets of the key target proteins. The calculated binding free energy (kcal/mol) for each complex is indicated. (A) Il22ra2 (−10.2 kcal/mol), (B) Ptgs2 (−9.5 kcal/mol), (C) Wnt1 (−9.3 kcal/mol), (D) Igfbp2 (−8.4 kcal/mol), (E) GZMB (−8.2 kcal/mol), (F) Lep (−7.8 kcal/mol), (G) Gfap (−7.8 kcal/mol), (H) Wnt10a (−7.7 kcal/mol). These results demonstrate stable binding interactions between the therapeutic compound AS-IV and all eight core targets identified from the PPI network and WGCNA, with Il22ra2 and Ptgs2 showing the strongest binding affinity.

    Article Snippet: Primary antibodies diluted in antibody diluent were applied and incubated at 4 °C overnight; the primary antibodies were as follows: PTGS2 (ABclonal, A3560, rabbit, 1:200), IGFBP2 (Proteintech, 66,644-1-IG, mouse, 1:200), WNT1 (ABclonal, A2475, rabbit, 1:200), LEP (bioss, bs-0409R, rabbit, 1:200), GFAP (Proteintech, 60,190-1-IG, mouse, 1:1000), β -catenin (huilanbio, ABB3523, rabbit, 1:200), and NF-κB p65 (Cell Signaling Technology, 8,242, rabbit, 1:200), with EDTA-based retrieval used for all targets.

    Techniques: Binding Assay

    Multiplex immunofluorescence imaging and semi-quantification of target proteins in femoral trabecular bone. Representative multiplex immunofluorescence images showing DAPI (nuclei), target protein staining, and merged overlays in the femoral trabecular region from Sham, OVX, and OVX-AS-IV-M treated rats. Panels show staining for (A) NF-κB p65, (B) Wnt1, (C) Gfap, (D) β-catenin, (E) Igfbp2, (F) Lep, and (G) Ptgs2. Scale bar, 50 μm. The corresponding semi-quantification of mean fluorescence intensity (MFI) for each marker is presented to the right of each image panel, normalized to the Sham group (set to 1). Data are presented as mean ± SD with individual data points overlaid. Statistical comparisons were performed using one-way ANOVA followed by Dunnett’s multiple-comparisons test. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Frontiers in Nutrition

    Article Title: Astragaloside IV modulates oxidative stress and osteoimmune–Wnt signaling in ovariectomized rats: an integrated study of RNA sequencing, molecular docking, and experimental validation

    doi: 10.3389/fnut.2026.1785452

    Figure Lengend Snippet: Multiplex immunofluorescence imaging and semi-quantification of target proteins in femoral trabecular bone. Representative multiplex immunofluorescence images showing DAPI (nuclei), target protein staining, and merged overlays in the femoral trabecular region from Sham, OVX, and OVX-AS-IV-M treated rats. Panels show staining for (A) NF-κB p65, (B) Wnt1, (C) Gfap, (D) β-catenin, (E) Igfbp2, (F) Lep, and (G) Ptgs2. Scale bar, 50 μm. The corresponding semi-quantification of mean fluorescence intensity (MFI) for each marker is presented to the right of each image panel, normalized to the Sham group (set to 1). Data are presented as mean ± SD with individual data points overlaid. Statistical comparisons were performed using one-way ANOVA followed by Dunnett’s multiple-comparisons test. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: Primary antibodies diluted in antibody diluent were applied and incubated at 4 °C overnight; the primary antibodies were as follows: PTGS2 (ABclonal, A3560, rabbit, 1:200), IGFBP2 (Proteintech, 66,644-1-IG, mouse, 1:200), WNT1 (ABclonal, A2475, rabbit, 1:200), LEP (bioss, bs-0409R, rabbit, 1:200), GFAP (Proteintech, 60,190-1-IG, mouse, 1:1000), β -catenin (huilanbio, ABB3523, rabbit, 1:200), and NF-κB p65 (Cell Signaling Technology, 8,242, rabbit, 1:200), with EDTA-based retrieval used for all targets.

    Techniques: Multiplex Assay, Immunofluorescence, Imaging, Staining, Fluorescence, Marker

    Effect of implanted fillers on the recruitment of PSCs and ingrowth of blood vessels following implantation in the periosteum of rat skull for a duration of 1 month. Scale bars, 100 μm. A Representative immunostainings of LepR+ PSCs, Emcn+ vessels, and OPN+ mature osteoblast in HA and PCL fillers. B , C Quantification of the relative Emcn+ vessel area in implants ( B ) and peri-implants ( C ). D Quantification of the relative LepR+ area in implants. Data are means ± SD. * P < 0.05, and *** P < 0.005 (unpaired two-tailed Student’s t test)

    Journal: Aesthetic Plastic Surgery

    Article Title: A Rat Model Investigation of Enhanced Facial Rejuvenation via PCL Microsphere-Induced Superior Collagen Neogenesis in the Supraperiosteal Plane

    doi: 10.1007/s00266-025-05503-6

    Figure Lengend Snippet: Effect of implanted fillers on the recruitment of PSCs and ingrowth of blood vessels following implantation in the periosteum of rat skull for a duration of 1 month. Scale bars, 100 μm. A Representative immunostainings of LepR+ PSCs, Emcn+ vessels, and OPN+ mature osteoblast in HA and PCL fillers. B , C Quantification of the relative Emcn+ vessel area in implants ( B ) and peri-implants ( C ). D Quantification of the relative LepR+ area in implants. Data are means ± SD. * P < 0.05, and *** P < 0.005 (unpaired two-tailed Student’s t test)

    Article Snippet: Mouse Leptin Receptor (LepR) biotinylated antibody (BAF497) was sourced from R&D systems (Minneapolis, MN, USA).

    Techniques: Two Tailed Test